Medigene AG Stock
Currently there is a rather positive sentiment for Medigene AG with 5 Buy predictions and 1 Sell predictions.
With a target price of €8.00 there is potential for a 106.986% increase which would mean more than doubling the current price of €3.87 for Medigene AG.
Our community identified positive and negative aspects for Medigene AG stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Medigene AG stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Medigene AG in the next few years
Performance of Medigene AG vs. its peers
|B.R.A.I.N. Biotechnology Research and Information Network AG||3.000%||-17.129%||-1.591%||-6.580%||-4.415%||-63.070%||-12.737%|
Other discussions about Medigene AG StockNew thread Forum
Medigene AG: Further encouraging results from long-term follow-up of AML patients in DC vaccine trial
Business news for the stock market
Planegg/Martinsried (08.02.2021/16:00) - Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the
Conference call today, 3.00 pm CET (9.00 am ET)
Planegg/Martinsried (28.01.2021) - 28 January 2021. The Executive Management of Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical
Medigene AG: Medigene expands patent protection of its technologies in key markets, the USA and Europe
Planegg/Martinsried (13.01.2021) - Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, was